Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
Unusual Options Activity Insight: OPKO Health
05:40pm, Monday, 03'rd Aug 2020
On Monday, shares of OPKO Health (NASDAQ: OPK) saw unusual options activity. After the option activity alert, the stock price moved up to $5.25. * Sentiment: BEARISH * Option Type: SWEEP * Trade Ty
OPKO Health (OPK) is a Great Momentum Stock: Should You Buy?
04:00pm, Monday, 03'rd Aug 2020
Does OPKO Health (OPK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Unusual Options Activity Insight: OPKO Health
12:00am, Monday, 03'rd Aug 2020
On Monday, shares of OPKO Health (NASDAQ: OPK) saw unusual options activity. After the option activity alert, the stock price moved up to $5.25.
Sentiment: BEARISH
Option Type:...
Creative Planning Boosts Position in Opko Health Inc. (NASDAQ:OPK)
08:54am, Sunday, 02'nd Aug 2020
Creative Planning boosted its position in shares of Opko Health Inc. (NASDAQ:OPK) by 381.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund ow
So far Saturday, August 1, NASDAQ is down -1.01% and the S&P is up 0.5%. Let’s take a look at
Why Shares of Coronavirus Stock Opko Health Plunged by 13% on Friday
10:57pm, Friday, 31'st Jul 2020
Opko Health (NASDAQ: OPK) -- considered a coronavirus stock thanks to its BioReference Laboratories, which has diagnostics products that test for the globe's top health threat at the moment -- closed
NextGen Healthcare (NXGN) Tops Q1 Earnings & Revenue Estimates
03:43pm, Friday, 31'st Jul 2020
NextGen (NXGN) benefited from its Recurring segment in Q1.
OPKO Health Grows Revenue by 33% on the Back of Its COVID-19 Tests
02:16pm, Friday, 31'st Jul 2020
Revenue at OPKO Health (NASDAQ: OPK) rose 33% year over year in the second quarter as the test-maker sold 2.2 million of its COVID-19 molecular tests. The pandemic remains a double-edged sword for OP
OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates
12:32pm, Friday, 31'st Jul 2020
OPKO Health's (OPK) second-quarter results benefit from increase in RAYALDEE prescriptions.
Wall Street Breakfast: Big Beats From Big Tech
07:04am, Friday, 31'st Jul 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify (click the highlighted links).
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
12:00am, Friday, 31'st Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
OPKO Health's (OPK) CEO Phillip Frost on Q2 2020 Results - Earnings Call Transcript
09:43pm, Thursday, 30'th Jul 2020
OPKO Health, Inc. (NASDAQ:OPK) Q2 2020 Earnings Conference Call July 30, 2020 4:45 PM ET Company Participants Yvonne Briggs – LHA, Investor Relations Phillip Frost – Chairman and Chief Executive O
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results
08:05pm, Thursday, 30'th Jul 2020
Conference call begins at 4:45 p.m. Eastern time todayMIAMI , July 30, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months e
OPKO Health (OPK) to Report Q2 Earnings: What's in Store?
01:33pm, Wednesday, 29'th Jul 2020
OPKO Health's (OPK) second-quarter results are likely to reflect solid performance from Products segment and RAYALDEE.
3 Great Stocks Under $10 | The Motley Fool
11:15am, Wednesday, 29'th Jul 2020
Investors can pick up a sizable number of shares in great companies without paying a fortune.
